(Press-News.org) Sound waves are filtered through the outer ear to the cochlea, where hair cells convert the sound into the electric impulses that travel through the auditory nerve to the brain. Cochlear hair cells are extremely sensitive to stress and loss of these cells is a common cause of deafness. The formation of tight junctions between cells allows epithelia to form barriers to prevent fluid and other molecules from moving freely throughout the body. In this issue of the Journal of Clinical Investigation, Saima Riazuddin and colleagues at the Cincinnati Children's Hospital, identify a role for the tricellular tight junction protein, TRIC, in cochlear hair cell preservation. A mutation in the TRIC gene had been previously linked to hearing loss in humans; however, the mechanism of hearing loss was unknown. Riazuddin and colleagues introduced the same mutation in mice and found that these mice lost cochlear hair cells. Their data suggests that mutated TRIC creates a toxic environment in the cochlea due to fewer tight cell junctions. In the accompanying commentary, Karen Avraham and colleagues from Tel Aviv University point out that this new mouse model will provide insights into human TRIC-associated deafness and provide insights into how tight junction function can be restored.
### END
Hearing loss associated with a lack of cell-cell junctions
2013-08-27
ELSE PRESS RELEASES FROM THIS DATE:
Cancerous cells from donor kidney linked to recipient skin cancer
2013-08-27
Patients that receive kidney transplants have an increased risk of an invasive form of skin cancer. It is unclear if donor tissue contributes to cancer formation. In this issue of the Journal of Clinical Investigation, Philippe Ratajczak and colleagues at INSERM demonstrate that donor tissue can lead to caner formation in transplant recipients. They examined tumor cells and transplant tissues from a small sample of kidney transplant patients that had subsequently developed skin squamous cell carcinoma (SCC). In one patient they identified the presence of skin tumor cells ...
A strategy for combating drug-resistant cancers
2013-08-27
Many cancer therapies function by activating proteins like Caspase-3 (CASP3) that promote cell death. Several forms of cancer develop resistance to these drugs by down regulating CASP3 through an unknown mechanism. In the absence of CASP3, tumor cells produce another cell death promoting protein CASP7, but it is rendered inactive by the X-linked inhibitor of apoptosis protein (XIAP). In this issue of the Journal of Clinical Investigation, Po-Huang Liang and colleagues at Academia Sinica identify a compound (I-Lys) that disrupts the interaction between CASP7 and XIAP. Release ...
Protease inhibitor resistance involves multiple stages of the HIV-1 life cycle
2013-08-27
HIV-1 protease inhibitors are very effective antiviral drugs. These drugs target HIV-1 proteases, which are required for viral replication. Despite the success of protease inhibitors for suppressing HIV-1, some patients do not respond to protease inhibitor therapy. For most patients, the lack of response is not due to mutation of the HIV-1 protease. In this issue of the Journal of Clinical Investigation, Robert Silcano and colleagues at Johns Hopkins University identify the effects of protease inhibitors on different stages of viral replication. The authors found that protease ...
Origin of a hereditary east Texas bleeding disorder
2013-08-27
A severe hereditary bleeding disorder was described in a large family from east Texas in 2001. The affected family members routinely had bruising, nosebleeds, massive blood loss following injury or surgery, and often required blood transfusions. Routine tests for functional components of the blood coagulation pathway did not reveal any obvious defects. Genomic sequencing revealed a mutation in the gene encoding coagulation factor 5 (FV), but it was not considered to contribute to disease, since clotting assays were normal. In this issue of the Journal of Clinical Investigation, ...
Scientists prevent preterm birth caused by gene-environment interactions
2013-08-27
CINCINNATI – New research in the Journal of Clinical Investigation provides evidence that gene-environment interactions are a major contributor to preterm birth and that using a combinatory treatment strategy can prevent preterm delivery in a mouse model.
In findings posted online Aug. 27, scientists from Cincinnati Children's Hospital Medical Center say their study provides important new insights into a major global health problem – one that remains stubbornly persistent in the United States. Preterm birth causes more than 1 million deaths a year and can leave premature ...
Study finds tumor suppressor may actually fuel aggressive leukemia
2013-08-27
CINCINNATI – New research in the Journal of Clinical Investigation suggests that blocking a protein normally credited with suppressing leukemia may be a promising therapeutic strategy for an aggressive form of the disease called acute myeloid leukemia (AML).
Researchers from Cincinnati Children's Hospital Medical Center report their results in a study posted online Aug. 27 by the journal.
The protein scientists targeted is a transcription factor known as RUNX1, which also plays an important role in helping regulate the normal development of blood cells. The researchers ...
Study identifies molecular process behind form of non-syndromic deafness
2013-08-27
CINCINNATI – Researchers identify an underlying molecular process that causes a genetic form of non-syndromic deafness in a new study that also suggests affected families may be at risk of damage to other organs.
A multi-national research team led by scientists at Cincinnati Children's Hospital Medical Center report their findings in a study posted online Aug. 27 by the Journal of Clinical Investigation. The research opens the door to finding possible treatments for the condition (called DFNB49 non-syndromic hearing loss) and points to possible cellular damage in other ...
Personalized AF management needed to close mortality gap
2013-08-27
Amsterdam, The Netherlands – Tuesday 27 August 2013: Personalised management is the only way to close the mortality gap for patients with atrial fibrillation (AF), according to an ESC consensus paper presented at ESC Congress 2013 by Professor Paulus Kirchhof (UK).
The Atrial Fibrillation competence NETwork (AFNET) and European Heart Rhythm Association (EHRA) consensus paper is published online in the European Journal of Pacing, Arrhythmias, and Cardiac Electrophysiology (EP-Europace)1 and presented during the ESC Congress session on personalised cardiology.
Professor ...
A genetic treasure hunting in sorghum may benefit crop improvement
2013-08-27
August 27, 2013, Shenzhen, China - A consortium of researchers from The University of Queensland, the Queensland Department of Agriculture, Fisheries and Forestry (DAFF Qld) and BGI has discovered that sorghum, a drought-tolerant African crop, holds vastly more genetic variation than previously reported. This study published in Nature Communications today provides an invaluable resource for the genetic improvement of sorghum and other grass species.
Sorghum is not only a food and feed cereal crop, but also can be used as the basis of biofuel. Its resistance to heat and ...
Novel approach to gene regulation can activate multiple genes simultaneously
2013-08-27
CAMBRIDGE, Mass. (August 27, 2013) – By creating a powerful new gene regulation system called CRISPR-on, Whitehead Institute researchers now have the ability to increase the expression of multiple genes simultaneously and precisely manipulate each gene's expression level. The system is effective in both mouse and human cells as well as in mouse embryos.
"CRISPR-on is a tool that will be very useful for studying many biological processes, particularly for studying gene functions and gene networks," says Whitehead Founding Member Rudolf Jaenisch. "In contrast to RNA interference, ...